YangHui

YangHui Biotech is a Shanghai-based biotechnology company specializing in the development of next-generation gene editing technologies. Founded by the prominent CRISPR scientist Dr. Hui Yang, the company focuses on the discovery and optimization of novel RNA-guided nucleases, including Cas12i, Cas12j (CasX/CasY), and Cas13 systems. Their proprietary PRECISE platform enables the rational engineering of compact and highly efficient gene editing tools for therapeutic applications. YangHui Biotech's research and development efforts are primarily directed toward treating genetic disorders in areas such as neurology and ophthalmology. The company is recognized for its significant contributions to the advancement of base editing and RNA editing modalities within the global biotech landscape.